Literature DB >> 1792461

A general parametric approach to the meta-analysis of randomized clinical trials.

A Whitehead1, J Whitehead.   

Abstract

Meta-analysis provides a systematic and quantitative approach to the summary of results from randomized studies. Whilst many authors have published actual meta-analyses concerning specific therapeutic questions, less has been published about comprehensive methodology. This article presents a general parametric approach, which utilizes efficient score statistics and Fisher's information, and relates this to different methods suggested by previous authors. Normally distributed, binary, ordinal and survival data are considered. Both the fixed effects and random effects model for treatments are described.

Mesh:

Year:  1991        PMID: 1792461     DOI: 10.1002/sim.4780101105

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  173 in total

1.  Comparative analyses of the studies of magnetic fields and cancer in electric utility workers: studies from France, Canada, and the United States.

Authors:  L I Kheifets; E S Gilbert; S S Sussman; P Guénel; J D Sahl; D A Savitz; G Thériault
Journal:  Occup Environ Med       Date:  1999-08       Impact factor: 4.402

Review 2.  [Meta-analysis as a tool for evaluation of evidence].

Authors:  A Koch; S Ziegler
Journal:  Med Klin (Munich)       Date:  2000-02-15

3.  The cost effectiveness of two new antiepileptic therapies in the absence of direct comparative data: a first approximation.

Authors:  Ben A van Hout; Dennis D Gagnon; Pauline McNulty; Anthony O'Hagan
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials.

Authors:  Jinying Lin; Weiya Zhang; Adrian Jones; Michael Doherty
Journal:  BMJ       Date:  2004-07-30

Review 5.  EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; N Arden; B Bannwarth; J Bijlsma; K-P Gunther; H J Hauselmann; G Herrero-Beaumont; K Jordan; P Kaklamanis; B Leeb; M Lequesne; S Lohmander; B Mazieres; E Martin-Mola; K Pavelka; A Pendleton; L Punzi; B Swoboda; R Varatojo; G Verbruggen; I Zimmermann-Gorska; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-10-07       Impact factor: 19.103

6.  Publication bias in clinical trials and economic analyses.

Authors:  N Freemantle; J Mason
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

Review 7.  Brief interventions and alcohol use.

Authors:  N Freemantle; P Gill; C Godfrey; A Long; C Richards; T A Sheldon; F Song; J Webb
Journal:  Qual Health Care       Date:  1993-12

8.  Evidence-based value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses.

Authors:  Henrik Petrowsky; Nicolas Demartines; Valentin Rousson; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

9.  The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.

Authors:  M-A Kedda; F Lose; D Duffy; E Bell; P J Thompson; J Upham
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

10.  Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies.

Authors:  Lei Xu; Xin Zhou; Lin Xu; Rong Yin
Journal:  Tumour Biol       Date:  2013-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.